[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345677-105":59,"doc-detail-345677-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cyth4-facilitates-renal-cell-carcinoma-via-enhancing-proliferation-and-likely-immune-evasion","CYTH4 Facilitates Renal Cell Carcinoma via Enhancing Proliferation and Likely Immune Evasion","","Cytohesin-4 (CYTH4), an ARF guanine nucleotide exchange factor, is investigated in clear cell renal cell carcinoma (ccRCC). CYTH4 is found to be dramatically upregulated in ccRCC and along disease progression, and it correlates with immune-suppressive features and poorer patient outcomes. A CYTH4-derived multigene panel, SigCYTH4NW, predicts inferior prognosis, aligns with the ccB poor-risk signature and immune checkpoint signature, and is enriched in tumor-associated macrophages. CYTH4 expression drives 786-0 proliferation and xenograft growth, links to pRb hypophosphorylation status, and supports immune evasion mechanisms relevant to primary ccRCC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cyth4-facilitates-renal-cell-carcinoma-via-enhancing-proliferation-and-likely-immune-evasion/345677/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cyth4-facilitates-renal-cell-carcinoma-via-enhancing-proliferation-and-likely-immune-evasion/345677.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does CYTH4 play in clear cell renal cell carcinoma (ccRCC)?","Question",{"text":112,"@type":113},"CYTH4 is dramatically upregulated in ccRCC and after ccRCC progression, and it is strongly associated with immune-suppressive features and poor outcome.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the CYTH4 gene expression signature (SigCYTH4NW) used clinically?",{"text":117,"@type":113},"SigCYTH4NW was derived from CYTH4’s gene expression network and, in retrospective studies, effectively predicted inferior prognosis and linked strongly with established poor-risk and immune checkpoint signatures.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental evidence supports CYTH4 promoting ccRCC progression?",{"text":121,"@type":113},"Stable CYTH4 expression increases 786-0 cell proliferation in vitro and promotes xenograft formation in vivo. Gene expression profiling shows CYTH4 networks relevant to primary ccRCC, especially immune evasion.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345677,1791347050,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Article  \nCYTH4 Facilitates Renal Cell Carcinoma via Enhancing Proliferation and Likely Immune Evasion  \nYing Dong 1,2, Yingying Su 1,2 and Damu Tang 1,2, *  \nAcademic Editor: Norbert Nass  \nReceived: 9 May 2026  \nRevised: 16 June 2026  \nAccepted: 17 June 2026  \nPublished: 22 June 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Medicine, McMaster University, Hamilton, ON L8S 4K1, Canada;  \n[dongy87@mcmaster.ca](dongy87@mcmaster.ca) (Y.D.); [suy36@mcmaster.ca](suy36@mcmaster.ca) (Y.S.)  \n2 The Research Institute of St Joe’s Hamilton, St Joseph’s Hospital, Hamilton, ON L8N 4A6, Canada  \n* Correspondence: [damut@mcmaster.ca](damut@mcmaster.ca); Tel.: +1-905-522-1155 (ext. 35168)  \nAbstract  \nCytohesin-4 (CYTH4), an ARF guanine nucleotide exchange factor, remains unknown in RCC pathogenesis. We report that CYTH4 was dramatically upregulated in clear cell renal cell carcinoma (ccRCC) and following ccRCC progression. CYTH4 was strongly associated with ccRCC’s immune-suppressive features and stratified ccRCC poor outcome. From CYTH4’s network/NW, a multigene panel, SigCYTH4NW, was derived. In retrospective studies,(1) SigCYTH4NW effectively predicted ccRCC’s inferior prognosis, was strongly associated with the well-validated poor risk ccB signature in four independent ccRCC cohorts (n = 1132), was significantly upregulated in ccB compared to ccA (favorable risk) tumors, was robustly correlated with an immune checkpoint signature (SigIC), and was predominantly expressed in tumor-associated macrophages, and (2) SigCYTH4NW effectively predicted poor prognosis and correlated with SigIC across 21 other cancer types. CYTH4 was expressed at low levels in 786-0 ccRCC cells; its stable expression promoted 786-0 cell proliferation in vitro and xenograft formation in vivo. CYTH4 bound PPP1R9B, which maintains pRb’s hypophosphorylation. 786-0 CYTH4 cells displayed intensive pRb hyperphosphorylation, suggesting that CYTH4 enhances cell proliferation partially by pRb inhibition. Gene expression profiling by RNA-seq revealed a 786-0 CYTH4 network that was relevant to primary ccRCC, particularly in the aspect of immune evasion. Collectively, this study supports CYTH4’s promoting ccRCC.  \nKeywords: CYTH4; renal cell carcinoma; xenografts; immune evasion; overall survival  \n1. Introduction  \nClear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer, accounting for 70–75% of cases, followed by papillary RCC (10–16%), chromophobe RCC (6%), and collecting duct carcinoma (0.5%) [1] . ccRCC is the top aggressive subtype and the predominant cause of kidney cancer-related mortality. The disease has a recurrence rate of approximately 20–40%, and 5–10% of patients progress to metastatic lethal ccRCC [2] . The mechanisms underlying ccRCC progression have been intensively investigated, leading to the discovery of the von Hippel–Lindau (VHL) hypoxia-inducible factor (HIF) axis asthe primary driver of ccRCC oncogenesis and progression [3–5] . As a result of these molecular alterations, ccRCC features hypoxia [6], metabolic reprogramming towards aerobic glycolysis (the Warburg effect) [6,7], and an immune-infiltrated but immunosuppressive microenvironment [8] . These features facilitate the management of ccRCC, as evidenced by the utilization of immune checkpoint blockade and targeted therapies with tyrosine kinase  \ninhibitors to vascular endothelial growth factor receptor (VEGFR) in treating metastatic ccRCC [9] . Nonetheless, these standard-of-care treatments are associated with limited effectiveness, which reflects our incomplete understanding of ccRCC’s etiology.  \nCytohesin-4 (CYTH4) or PSCD4 is a member of the cytohesin family—CYTH1, CYTH2, CYTH3, and CYTH4—of ADP-ribosylation factor (ARF) guanine nucleotide exchange factors (GEFs) [10–12] . The family membe","cbCaimpzrJI4PXV5","https://ap.wps.com/l/cbCaimpzrJI4PXV5","pdf",17047881,23,"English","# Abstract\n# Introduction\n## CYTH4 and cytohesin family background\n## Rationale for investigating CYTH4 in ccRCC","[{\"question\":\"What role does CYTH4 play in clear cell renal cell carcinoma (ccRCC)?\",\"answer\":\"CYTH4 is dramatically upregulated in ccRCC and after ccRCC progression, and it is strongly associated with immune-suppressive features and poor outcome.\"},{\"question\":\"How was the CYTH4 gene expression signature (SigCYTH4NW) used clinically?\",\"answer\":\"SigCYTH4NW was derived from CYTH4’s gene expression network and, in retrospective studies, effectively predicted inferior prognosis and linked strongly with established poor-risk and immune checkpoint signatures.\"},{\"question\":\"What experimental evidence supports CYTH4 promoting ccRCC progression?\",\"answer\":\"Stable CYTH4 expression increases 786-0 cell proliferation in vitro and promotes xenograft formation in vivo. Gene expression profiling shows CYTH4 networks relevant to primary ccRCC, especially immune evasion.\"}]","CYTH4 Facilitates Renal Cell Carcinoma via Enhancing Proliferation and Likely Immune Evasion | PDF",1790058563,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1484a4bf4c8fcb15dbe7a823c33802c2.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0801234a4fadb5a88a4c7fe10b4e5c25.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7c572d9cbf270b078ee2634d414c5be.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49d506be5fe9bb95f925d67536d55430.webp",980,1385]